NCT01895517View on ClinicalTrials.gov

CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening （CITRUS Study）

PHASE4CompletedINTERVENTIONAL
Enrollment

18,471

Participants

Timeline

Start Date

June 7, 2013

Primary Completion Date

November 30, 2022

Study Completion Date

May 31, 2023

Conditions
Cervical Cancer
Interventions
OTHER

LBC

Cervical cancer screening by using liquid based cytology as a standard screening modality

OTHER

LBC plus HPV DNA testing

Cervical cancer screening by using liquid based cytology plus HPV DNA testing as an experimentally screening modality

Trial Locations (1)

160-8582

School of Medicine, Keio University, Shinjuku

All Listed Sponsors
collaborator

Keio University

OTHER

collaborator

Jikei University School of Medicine

OTHER

lead

Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan

OTHER

NCT01895517 - CervIcal Cancer Screening Trial by Randomization of HPV Testing Intervention for Upcoming Screening （CITRUS Study） | Biotech Hunter | Biotech Hunter